Back
Range Cancer Therapeutics ETF Vs. Korro Bio Industry Stock Comparison
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.50
Seasonality Move:
1.85%
Sell
47
KRRO
Korro Bio
Last Price:
54.51
Seasonality Move:
51.42%
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $14.80. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Korro Bio (KRRO)
is a Sell
Is Korro Bio a Buy, Sell or Hold?
- The current Korro Bio [KRRO] share price is $55.01. The Score for KRRO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KRRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $14.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
KRRO Stock Price Chart
CNCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 45.09 | Sell |
Chaikin Money Flow: | -2025 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.73 - 15.45) | Sell |
Bollinger Bands (100): | (14.08 - 15.46) | Buy |
KRRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.92 | Buy |
Relative Strength Index (14 RSI): | 44.75 | Sell |
Chaikin Money Flow: | -239219 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.47 - 75.21) | Sell |
Bollinger Bands (100): | (33.91 - 58.81) | Buy |
CNCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.36 | Sell |
20-day SMA: | 15.14 | Sell |
50-day SMA: | 15.08 | Sell |
200-day SMA: | 15.09 | Sell |
8-day EMA: | 15.24 | Sell |
20-day EMA: | 15.16 | Sell |
50-day EMA: | 15.03 | Sell |
200-day EMA: | 14.63 | Buy |
KRRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.77 | Sell |
20-day SMA: | 66.99 | Sell |
50-day SMA: | 49.78 | Buy |
200-day SMA: | 51.83 | Buy |
8-day EMA: | 64.4 | Sell |
20-day EMA: | 62.15 | Sell |
50-day EMA: | 54.74 | Buy |
200-day EMA: | 49.56 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Korro Bio Earnings Growth & KRRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.16 per share, and a decrease next year of $0.40 per share.
Range Cancer Therapeutics ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Korro Bio Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |